Rationale for using combinations of short-acting insulin analogue and NPH insulin at mealtime in the treatment of type 1 diabetes mellitus
- 1 November 1999
- journal article
- conference paper
- Vol. 12, 737-744
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Insulin analogues and their potential in the management of diabetes mellitusDiabetologia, 1999
- Glycemic control in patients with diabetes in Finland.Diabetes Care, 1999
- Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.Diabetes Care, 1999
- Use of the short-acting insulin analogue lispro in intensive treatment of Type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-mealDiabetic Medicine, 1998
- Intensified insulin therapy and the risk of severe hypoglycaemiaDiabetologia, 1997
- Long-term intensive insulin therapy in IDDM: Effects on HbA(1c), risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia1996
- Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDMDiabetologia, 1994
- Nocturnal Blood Glucose Control in Type I Diabetes MellitusDiabetes Care, 1993
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993